Skip links and keyboard navigation

PAH supports Men’s Health Week

16 June 2017

This Men’s Health Week, Princess Alexandra Hospital (PAH) staff showed their support of men’s health by raising more than $500 for the PA Research Foundation’s MANDATE campaign and by facilitating 50 health checks.

Yesterday, ‘Go Blue or Maroon for MANDATE Day’ at PAH saw units across the hospital donning blue or Maroon to raise money to support men’s health research at PAH.

The team in Radiation Oncology all purchased and wore MANDATE t-shirts in support of the cause and decorated their department.

Radiation Oncology Nurse Denise Dizon said MANDATE was a great opportunity for the department to raise funds to support research that would one day benefit PAH patients.

“Many of the patients we see are men who are receiving treatments for prostate cancer and head and neck cancer,” she said.  

In the Main Foyer of the hospital, there were also free skin and lifestyle health checks on offer.

The Metro South Public Health Unit (MSPHU) held a morning tea in support of the event. 

Phil Rocha who coordinated the fundraiser at MSPHU said it was a big hit.

“The stall we had selling MANDATE merchandise went really well. All the team enjoyed being a part of the fundraiser and doing our bit to support men’s health research,” he said.

The MANDATE campaign will run until July 31, to learn more visit: www.mandate.org.au.

Last updated 16 June 2017
Last reviewed 16 June 2017

Other news

Bowel cancer early detection is key

Bowel Cancer—early detection is key

Bowel cancer is Australia’s second biggest cancer killer but is one of the most treatable types if found early. This Bowel Cancer Awareness Month Princess Alexandra Hospital Health Promotion Officer Abby Fraser was encouraging the community to ‘Make No. 2 your No. 1 priority’ and participate in the free National Bowel Cancer Screening Program.

Dr Darshan Shah clot dissolving drug trial for stroke patients

Trial tests time-saving clot-dissolving drug

A clot-dissolving drug trial could see stroke patients receive life-saving treatment faster. The Princess Alexandra Hospital Stroke Unit was participating in a trial that aimed to show Tenecteplase, a clot-dissolving drug currently used in heart attack patients, could reduce treatment time for stroke patients by an hour.